Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxaliplatin and Taxotere in Metastatic Bladder Cancer
NCT00186277Phase 2Completed
- Sponsor
- Stanford University
- Start
- Dec 2003
- Primary completion
- Dec 2006
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin, docetaxel in bladder cancer, sponsored by Stanford University. Started Dec 2003; status: completed.
02
Drugs
oxaliplatindocetaxel
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT00186277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00186277.